Work

A competitive antagonist of NMDA receptors CGP 40116 attenuates experimental symptoms of schizophrenia evoked by MK-801.

Year: 2003

Type: article

Source: PubMed

Authors: Wojciech Zajaczkowski, Anna Czyrak, Krzystof Wedzony

Institutions: Maj Institute of Pharmacology, Polish Academy of Sciences

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2403944350

FWCI:

Cites: 38

Cited by: 14

Related to: 10